The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis (Q50050279)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2014

Language	Label	Description	Also known as
English	The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis	scientific article published in November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Jérôme Avouac

1

object named as

Jérôme Avouac

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

11

object named as

Georg Schett

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

author name string

Katrin Palumbo-Zerr

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Nadira Ruzehaji

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Michal Tomcik

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Pawel Zerr

5

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Clara Dees

6

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Alfiya Distler

7

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Christian Beyer

8

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Holm Schneider

9

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Oliver Distler

10

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Yannick Allanore

12

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Jörg H W Distler

13

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

publication date

1 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

66

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

11

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

3140-3150

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Systemic sclerosis: a prototypic multisystem fibrotic disorder

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Transforming growth factor beta as a therapeutic target in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Cytoplasmic Accumulation of the Nuclear Receptor CAR by a Tetratricopeptide Repeat Protein in HepG2 Cells

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

CAR, the continuously advancing receptor, in drug metabolism and disease

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Decreased PXR and CAR inhibit transporter and CYP mRNA Levels in the liver and intestine of mice with collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Differential Transactivation by Two Isoforms of the Orphan Nuclear Hormone Receptor CAR

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Primary biliary cirrhosis as a collagen disease

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

STUDIES ON THE PATHOGENESIS OF RHEUMATOID JOINT INFLAMMATION. II. INTRACYTOPLASMIC PARTICULATE COMPLEXES IN RHEUMATOID SYNOVIAL FLUIDS.

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Inhibition of sumoylation prevents experimental fibrosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Animal models of systemic sclerosis: prospects and limitations

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Activation of pregnane X receptor inhibits experimental dermal fibrosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Effect of Nuclear Receptor Downregulation on Hepatic Expression of Cytochrome P450 and Transporters in Chronic Hepatitis C in Association with Fibrosis Development

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002/ART.38819

21 January 2018

Identifiers

10.1002/ART.38819

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/25155144

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50050279&oldid=2236036619"